ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 650021 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 650021; 2) Community: the network communities that were significantly associated with the response to NSC 650021; 3) Molecule: the relationships between components within communities and NSC 650021; 4) MDR: the compounds that were significantly associated with the NSC 650021.

NSC Compound Enrichment Correlation
NSC 666160 Bis[1-(4-methylpiperidino)-4-(2-pyridyl)-2,3-diazapenta 1,3-dien-1-thiolato-N',N3,S]nitrato-bismuth(III) 0.0177048892222174 -0.089010062
NSC 675772 Glutamic acid, N-[4-[[6-(trifluoromethyl)-2-quinoxalinyl] amino]benzoyl]-, diethyl ester 0.0177048892222174 0.083975069
NSC 678102 4H-1-Benzopyran-4-one, 2-(1,3-benzodioxol-5-yl)-5-hydroxy-3,7-dimethoxy- 0.0177048892222174 0.058792497
NSC 725671 5,6-Dihydro-5,11-dioxo-6-(3-amino-1-propyl)-11H-indeno[1,2-c ]isoquinoline hydrochloride 0.0177048892222174 0.051425344
NSC 740510 6-(11-aminoundecyl)-5,6-dihydro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride 0.0177048892222174 -0.077082717
NSC 758662 Lovastatin [USAN] 0.0177048892222174 0.15656396
NSC 633113 [1,2,3,4]Tetrathiocino[5,6-d:7,8-d']diimidazole- 2,9-dithione, 1,3,8,10-tetraethyl-1,2,3,8,9,10-hexahydro- 0.0193573267900279 0.017744706
NSC 661581 2-Azabicyclo[16.3.1]docosane, geldanamycin deriv. 0.0193573267900279 -0.10381786
NSC 693702 Gambogic acid 0.0193573267900279 0.085934381
NSC 683766 Benzoic acid, 4-[[(2-bromi-3,6-dioxo-1,4-cyclohexadienyl)methyl]-amino]-, 1-adamantyl ester 0.0193573267900282 0.042684819
Total:50  Current:20    [First] [Prev] [Next] [Last]